Evidence map›Paper›PMID 32495676›Full record

ArticleThe American journal of hospice & palliative care2021

Conversations on Cancer Chemotherapy Cessation in Patients With Advanced Cancer: Qualitative Findings From a Multi-Institutional Study.

Jeremiah Stout, Ashok Kumbamu, Jon Tilburt, Cara Fernandez, Gail Geller, Barbara Koenig, Heinz-Josep Lenz, Aminah Jatoi

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of hospice & palliative care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jeremiah Stout6915Mayo Clinic, Rochester, MN, USA.
Ashok Kumbamu6915Mayo Clinic, Rochester, MN, USA.
Jon Tilburt6915Mayo Clinic, Rochester, MN, USA.
Cara Fernandez6915Mayo Clinic, Rochester, MN, USA.
Gail GellerBerman Institute of Bioethics, Johns Hopkins Bloomberg School of Public Health, 1466Johns Hopkins University, Baltimore, MD, USA.
Barbara KoenigInstitute for Health Aging, 8785University of California San Francisco, CA, USA.
Heinz-Josep Lenz5116University of Southern California, Los Angeles, CA, USA.
Aminah Jatoi6915Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-1081-189X
Mayo Clinic in Arizona · USJohns Hopkins University · USUniversity of California, San Francisco · USUniversity of Southern California · US

Funding

Assessing Patient Experience in Cancer Care: An Observational Communication StudyR01AT006515 · NCCIH · MAYO CLINIC ROCHESTER · PI TILBURT, JON C · 2011 to 2015
$3.5M
NCCIH NIH HHS R01 AT006515
6 · The paper itself

Abstract

purposeAs many as 20% of oncology patients receive chemotherapy in the last 14 days of their lives. This study characterized conversations between patients and cancer clinicians on chemotherapy cessation in the setting of advanced cancer.

methodsThis 3-site study captured real-time, audio-recorded interviews between oncology clinicians and patients with cancer during actual clinic visits. Audio-recordings were reviewed for discussion of chemotherapy cessation and were analyzed qualitatively.

resultsAmong 525 recordings, 14 focused on stopping chemotherapy; 14 patients participated with 11 different clinicians. Two types of nonmutually exclusive conversation elements emerged: direct and specific elements that described an absence of effective therapeutic options and indirect elements. An example of a direct element is as follows: "…You know this is…always really tough…But I-I think that you may need more help…I think we're close to stopping chemotherapy…And hospice is really helpful to have in place…" In contrast, the second conversation element was more convoluted: "…transplant is not an option and surgery is not an option…The options…are taking a pill…It doesn't shrink the tumor…It may help you live a little longer. But I'm worried if [you] had the pill, it's still a therapy and it still has side effects. I [am] worried if I give it to you now, that you're so weak, it will make you worse." No relationship seemed apparent between conversation elements and chemotherapy cessation.

conclusionsConversations on chemotherapy cessation are complex; multiple factors appear to drive the decision to stop.

Indexed as

Drug-Related Side Effects and Adverse ReactionsNeoplasmsCommunicationHumansMedical Oncologycessationchemotherapyconversationsend of lifequalitativestopping

Identifiers

PMID32495676
PMCPMC8189263
OpenAlexW3028709865

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.